Methods for labeling nonphagocytic cells with mr contrast agents

Joseph A. Frank, Stasia A. Anderson, Ali Syed Arbab

Research output: Chapter in Book/Report/Conference proceedingChapter

5 Citations (Scopus)

Abstract

The ability to monitor the migration and trafficking of cells in target tissues using noninvasive imaging techniques may contribute to the understanding of the role that cellular therapy will play in repair, replacement, and treatment of diseases. There are a variety of imaging approaches and methods that use contrast agents to label cells, including single-photon emission tomography with labeling done by indium oxine and technetium99m chelates, positron emission tomography by incubating cells with copper 64 pyruvaldehyde-bis (N4-methylthiosemicarbazone), optical or bioluminescent imaging by incorporating luciferase or green fluorescent protein-like molecules into the cell genome, and magnetic resonance imaging (MRI) using paramagnetic contrast agents (e.g., gadolinium chelates, gadolinium nanoparticles, manganese chloride, etc.) or superparamagnetic iron oxide (SPIO) nanoparticle contrast agents for ex vivo labeling and in vivo cell tracking. This chapter will focus on the methods for intracellular uptake of MRI contrast agents, the methods used to label ex vivo nonphagocytic cells (i.e., primary cells, including stem cells, progenitor cells, or terminally differentiated cells such as lymphocytes, B-cells, neurons, and beta cells in islets) with paramagnetic contrast agents and SPIO nanoparticles, the validation steps used to determine if the agents are toxic or alter cell function proliferation or differential capacity, and the steps needed to translate cell labeling techniques from bench to bedside.

Original languageEnglish (US)
Title of host publicationMolecular and Cellular MR Imaging
PublisherCRC Press
Pages295-324
Number of pages30
ISBN (Electronic)9781420004090
ISBN (Print)0849372526, 9780849372520
StatePublished - Jan 1 2007
Externally publishedYes

Fingerprint

Labeling
Contrast Media
Imaging techniques
Gadolinium
Magnetic resonance
Nanoparticles
Labels
Pyruvaldehyde
Positron emission tomography
Lymphocytes
Poisons
Stem Cells
Magnetic Resonance Imaging
Cell Tracking
Green Fluorescent Proteins
Stem cells
Luciferases
Play Therapy
Neurons
Tomography

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Frank, J. A., Anderson, S. A., & Arbab, A. S. (2007). Methods for labeling nonphagocytic cells with mr contrast agents. In Molecular and Cellular MR Imaging (pp. 295-324). CRC Press.

Methods for labeling nonphagocytic cells with mr contrast agents. / Frank, Joseph A.; Anderson, Stasia A.; Arbab, Ali Syed.

Molecular and Cellular MR Imaging. CRC Press, 2007. p. 295-324.

Research output: Chapter in Book/Report/Conference proceedingChapter

Frank, JA, Anderson, SA & Arbab, AS 2007, Methods for labeling nonphagocytic cells with mr contrast agents. in Molecular and Cellular MR Imaging. CRC Press, pp. 295-324.
Frank JA, Anderson SA, Arbab AS. Methods for labeling nonphagocytic cells with mr contrast agents. In Molecular and Cellular MR Imaging. CRC Press. 2007. p. 295-324
Frank, Joseph A. ; Anderson, Stasia A. ; Arbab, Ali Syed. / Methods for labeling nonphagocytic cells with mr contrast agents. Molecular and Cellular MR Imaging. CRC Press, 2007. pp. 295-324
@inbook{b9361aa3a74d47eeb8218392a7d1c060,
title = "Methods for labeling nonphagocytic cells with mr contrast agents",
abstract = "The ability to monitor the migration and trafficking of cells in target tissues using noninvasive imaging techniques may contribute to the understanding of the role that cellular therapy will play in repair, replacement, and treatment of diseases. There are a variety of imaging approaches and methods that use contrast agents to label cells, including single-photon emission tomography with labeling done by indium oxine and technetium99m chelates, positron emission tomography by incubating cells with copper 64 pyruvaldehyde-bis (N4-methylthiosemicarbazone), optical or bioluminescent imaging by incorporating luciferase or green fluorescent protein-like molecules into the cell genome, and magnetic resonance imaging (MRI) using paramagnetic contrast agents (e.g., gadolinium chelates, gadolinium nanoparticles, manganese chloride, etc.) or superparamagnetic iron oxide (SPIO) nanoparticle contrast agents for ex vivo labeling and in vivo cell tracking. This chapter will focus on the methods for intracellular uptake of MRI contrast agents, the methods used to label ex vivo nonphagocytic cells (i.e., primary cells, including stem cells, progenitor cells, or terminally differentiated cells such as lymphocytes, B-cells, neurons, and beta cells in islets) with paramagnetic contrast agents and SPIO nanoparticles, the validation steps used to determine if the agents are toxic or alter cell function proliferation or differential capacity, and the steps needed to translate cell labeling techniques from bench to bedside.",
author = "Frank, {Joseph A.} and Anderson, {Stasia A.} and Arbab, {Ali Syed}",
year = "2007",
month = "1",
day = "1",
language = "English (US)",
isbn = "0849372526",
pages = "295--324",
booktitle = "Molecular and Cellular MR Imaging",
publisher = "CRC Press",

}

TY - CHAP

T1 - Methods for labeling nonphagocytic cells with mr contrast agents

AU - Frank, Joseph A.

AU - Anderson, Stasia A.

AU - Arbab, Ali Syed

PY - 2007/1/1

Y1 - 2007/1/1

N2 - The ability to monitor the migration and trafficking of cells in target tissues using noninvasive imaging techniques may contribute to the understanding of the role that cellular therapy will play in repair, replacement, and treatment of diseases. There are a variety of imaging approaches and methods that use contrast agents to label cells, including single-photon emission tomography with labeling done by indium oxine and technetium99m chelates, positron emission tomography by incubating cells with copper 64 pyruvaldehyde-bis (N4-methylthiosemicarbazone), optical or bioluminescent imaging by incorporating luciferase or green fluorescent protein-like molecules into the cell genome, and magnetic resonance imaging (MRI) using paramagnetic contrast agents (e.g., gadolinium chelates, gadolinium nanoparticles, manganese chloride, etc.) or superparamagnetic iron oxide (SPIO) nanoparticle contrast agents for ex vivo labeling and in vivo cell tracking. This chapter will focus on the methods for intracellular uptake of MRI contrast agents, the methods used to label ex vivo nonphagocytic cells (i.e., primary cells, including stem cells, progenitor cells, or terminally differentiated cells such as lymphocytes, B-cells, neurons, and beta cells in islets) with paramagnetic contrast agents and SPIO nanoparticles, the validation steps used to determine if the agents are toxic or alter cell function proliferation or differential capacity, and the steps needed to translate cell labeling techniques from bench to bedside.

AB - The ability to monitor the migration and trafficking of cells in target tissues using noninvasive imaging techniques may contribute to the understanding of the role that cellular therapy will play in repair, replacement, and treatment of diseases. There are a variety of imaging approaches and methods that use contrast agents to label cells, including single-photon emission tomography with labeling done by indium oxine and technetium99m chelates, positron emission tomography by incubating cells with copper 64 pyruvaldehyde-bis (N4-methylthiosemicarbazone), optical or bioluminescent imaging by incorporating luciferase or green fluorescent protein-like molecules into the cell genome, and magnetic resonance imaging (MRI) using paramagnetic contrast agents (e.g., gadolinium chelates, gadolinium nanoparticles, manganese chloride, etc.) or superparamagnetic iron oxide (SPIO) nanoparticle contrast agents for ex vivo labeling and in vivo cell tracking. This chapter will focus on the methods for intracellular uptake of MRI contrast agents, the methods used to label ex vivo nonphagocytic cells (i.e., primary cells, including stem cells, progenitor cells, or terminally differentiated cells such as lymphocytes, B-cells, neurons, and beta cells in islets) with paramagnetic contrast agents and SPIO nanoparticles, the validation steps used to determine if the agents are toxic or alter cell function proliferation or differential capacity, and the steps needed to translate cell labeling techniques from bench to bedside.

UR - http://www.scopus.com/inward/record.url?scp=84992755659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992755659&partnerID=8YFLogxK

M3 - Chapter

SN - 0849372526

SN - 9780849372520

SP - 295

EP - 324

BT - Molecular and Cellular MR Imaging

PB - CRC Press

ER -